Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06996951 · ClinicalTrials.gov registry record · Phase 3
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
A Phase 3 study of Cystic Fibrosis (CF) and Chronic Rhinosinusitis (CRS), sponsored by Indiana University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06996951 is a Phase 3 study of Cystic Fibrosis (CF) and Chronic Rhinosinusitis (CRS) that is actively recruiting participants, run by Indiana University. The registered enrollment target is 64 participants, below the 136-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06996951, a Phase 3 study of Cystic Fibrosis (CF) and Chronic Rhinosinusitis (CRS), is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are doing this study to discover if it is appropriate for people with Cystic Fibrosis (CF) on highly effective modulator therapy (HEMT) to stop using certain standard Sino nasal therapies such as high-volume nasal saline irrigations, topical nasal steroids, and topical nasal antibiotics. They are also going to study the fluid inside the nose to see if there are changes when stopping these therapies. Right now, they are not sure if it is suggested to stop these treatments when patients begin highly effective modulator therapy (HEMT)
Conditions Studied
Interventions
- OTHER STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID
- DRUG CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID
Study Locations (1)
Indiana
- Indiana University Health - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2025-07-02 |
| Est. Completion | 2026-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06996951
The ClinicalTrials.gov registry entry for NCT06996951 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 136-participant average among 14 other Cystic Fibrosis (CF) trials with a reported enrollment target (53% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cystic Fibrosis (CF) appearing as the primary indexed condition, and to 2 interventions - of which STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID is the first listed.
NCT06996951 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06996951 about?
NCT06996951 is a clinical study titled "Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy". The investigators are doing this study to discover if it is appropriate for people with Cystic Fibrosis (CF) on highly effective modulator therapy (HEMT) to stop using certain standard Sino nasal therapies such as high-volume nasal saline irrigations, topical nasal steroids, and topical nasal antibi...
What is the current status of trial NCT06996951?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 64 participants. The study started on 2025-07-02. Estimated completion is 2026-07.
What conditions does trial NCT06996951 study?
This clinical trial studies the following conditions: Cystic Fibrosis (CF), Chronic Rhinosinusitis (CRS).
What interventions are being tested in trial NCT06996951?
The interventions under investigation include: STOP NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID (OTHER), CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID (DRUG).
Who is sponsoring clinical trial NCT06996951?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06996951 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis (CF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
RECRUITING
-
Personalized Mobile Health Platform to Promote Physical Activity in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
RECRUITING
-
Study With Phage for CF Subjects With Pseudomonas Lung Infection
RECRUITING · Phase 2
-
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
RECRUITING
-
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.